Optimising Gallium-68 (⁶⁸Ga) DOTATATE PET/CT Reconstruction in Neuroendocrine Tumours: A Paired Comparison of...

Objective The aim was to determine whether "Q.Clear" (GE Healthcare, Bayesian Penalised Likelihood (BPL) reconstruction algorithm) of Gallium-68 (⁶⁸Ga) DOTATATE PET scans at different penalisation factors (β) could improve qualitative and quantitative image parameters compared with the standard Ordered Subsets Expectation Maximisation (OSEM), VPFX reconstruction. Methods  Twenty-five PET/CT scans performed 60 minutes after injection of 110-224 MBq (activity 153 MBq/kg) of ⁶⁸Ga-DOTATATE on a GE Discovery 710 PET/CT scanner were reconstructed using VPFX (2 iterations, 24 subsets) and Q.Clear with β values ranging from 200-1200.  A representative neuroendocrine tumour (NET) lesion and three reference regions (liver, spleen, and L3 bone marrow) were measured for standardised uptake values (SUVₘₐₓ/mean/peak/SD), signal-to-noise ratio (SNR = SUVₘₐₓ/liver SUV_SD), and signal-to-background ratio (SBR = SUVₘₐₓ/liver SUV_mean). A blinded qualitative assessment by a PET specialist scored image quality on a 5-point scale and evaluated the presence and severity of artefacts. Results  BPL lesion SUVₘₐₓ and SNR were greater than VPFX for all β values (p < 0.05). Although BPL lesion SBR values were higher than VPFX, no β reached statistical significance. Similar patterns were observed for reference organ comparisons. Qualitative analysis showed a preference for β = 800, which yielded the best image quality with lower artefact scores. Conclusion  BPL reconstruction of ⁶⁸Ga-DOTATATE PET data in patients with NETs improves SNR in tumour lesions and normal organs and increases SUVₘₐₓ in tumours. Combining these results with the preferred image quality at β = 800, BPL reconstruction can be considered a viable alternative for future reconstruction methods when assessing NETs.